Alan I. So

2660 Oak St
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 171 publications

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Journal: Future oncology (London, England)

Published: June 19, 2026

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Journal: Endocrine oncology (Bristol, England)

Published: December 09, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: September 10, 2025

Examining the association between real-world extended vs. standard pelvic lymph node dissection and early and late oncologic outcomes in men undergoing radical prostatectomy.

Examining the association between real-world extended vs. standard pelvic lymph node dissection and early and late oncologic outcomes in men undergoing radical prostatectomy.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: September 02, 2025

Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Journal: Oncogene

Published: August 07, 2025

Summary of changes in the 2025 Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer.

Summary of changes in the 2025 Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: August 06, 2025

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update).

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update).

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: August 06, 2025

A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study.

A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study.

Journal: The Journal of urology

Published: July 25, 2025

Summary of changes in the 2025 Canadian Urological Association-Canadian Urologic Oncology Group Guideline on metastatic castration-naive and castration-sensitive prostate cancer.

Summary of changes in the 2025 Canadian Urological Association-Canadian Urologic Oncology Group Guideline on metastatic castration-naive and castration-sensitive prostate cancer.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: May 21, 2025

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update).

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update).

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: May 21, 2025

Editorial Expression of Concern: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Editorial Expression of Concern: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Journal: Oncogene

Published: April 10, 2025

Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.

Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.

Journal: The Journal of urology

Published: April 09, 2025

Showing 1-12 of 171

Last Updated: 09/26/2026